Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.3551
+0.0107 (3.11%)
Oct 8, 2026, 10:31 AM EDT - Market open
Alps Group Market Cap
Alps Group has a market cap or net worth of $59.09 million as of October 8, 2026. It is the 29,452nd most valuable company in the world and the 4,583rd biggest in the United States. Its market cap has increased by 11.99% in one year.
Market Cap
59.09M
Enterprise Value
59.22M
1-Year Change
11.99%
Global Rank
Country Rank
#4,583 United States
Category
ChartMarket Cap Chart
Since December 23, 2021, Alps Group's market cap has decreased from $143.00M to $59.09M, a decrease of -58.68%. That is a compound annual growth rate of -16.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 59.09M | -59.16% |
| Dec 31, 2025 | 144.67M | 230.19% |
| Dec 30, 2024 | 43.81M | -50.64% |
| Dec 29, 2023 | 88.76M | -41.77% |
| Dec 30, 2022 | 152.44M | 6.93% |
| Dec 30, 2021 | 142.56M | -0.30% |
| Dec 23, 2021 | 143.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortress Biotech | 69.70M |
| Adicet Bio | 69.65M |
| Champions Oncology | 69.11M |
| Cingulate | 69.07M |
| Spero Therapeutics | 67.55M |
| Kalaris Therapeutics | 67.37M |
| PDS Biotechnology | 67.17M |
| XBiotech | 66.46M |